Perspective Therapeutics's market cap is currently $191.95M. The company's EPS TTM is $-0.928; its P/E ratio is ―; Perspective Therapeutics is scheduled to report earnings on March 27, 2025, and the estimated EPS forecast is $-0.27. See an overview of income statement, balance sheet, and cash flow financials.

	Dec 23	Dec 22	Jun 22	Jun 21	Jun 20
Income Statement
Total Revenue	$ 1.43M	$ 7.10M	$ 10.79M	$ 10.05M	$ 9.68M
Gross Profit	$ 1.43M	$ 1.63M	$ 4.62M	$ 5.12M	$ 5.12M
Operating Income	$ -40.94M	$ -15.18M	$ -7.39M	$ -3.44M	$ -3.48M
EBITDA	$ -39.96M	$ -14.84M	$ -7.39M	$ -3.43M	$ -3.48M
Net Income	$ -46.51M	$ -14.67M	$ -7.15M	$ -3.19M	$ -3.27M
Balance Sheet
Cash & Short-Term Investments	$ 9.24M	$ 43.76M	$ 55.89M	$ 63.83M	$ 2.39M
Total Assets	$ 97.89M	$ 58.09M	$ 64.44M	$ 70.42M	$ 8.70M
Total Debt	$ 2.55M	$ 0.00	$ 524.00K	$ 776.00K	$ 1.00M
Net Debt	$ -6.69M	$ -20.99M	$ -55.37M	$ -63.05M	$ -1.39M
Total Liabilities	$ 22.71M	$ 3.45M	$ 3.16M	$ 3.01M	$ 2.98M
Stockholders' Equity	$ 75.18M	$ 54.64M	$ 61.28M	$ 67.41M	$ 5.72M
Cash Flow
Free Cash Flow	$ -37.98M	$ -12.47M	$ -7.98M	$ -3.22M	$ -3.91M
Operating Cash Flow	$ -36.91M	$ -12.17M	$ -7.71M	$ -2.84M	$ -3.64M
Investing Cash Flow	$ 24.37M	$ -57.68M	$ -284.00K	$ -410.00K	$ -287.00K
Financing Cash Flow	$ 785.00K	$ 56.00K	$ 56.00K	$ 64.68M	$ 994.00K

Currency in USD

Perspective Therapeutics Earnings and Revenue History

Income Statement >

Perspective Therapeutics Debt to Assets

Balance Sheet >

Perspective Therapeutics Cash Flow

Cash Flow >

Perspective Therapeutics Forecast EPS vs Actual EPS

Earnings >

Become an Expert with TipRanks Premium

What am I Missing?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing